102 related articles for article (PubMed ID: 19572347)
21. Which antithrombotic to use during PCI?
Jolly SS; Yusuf S
Eur Heart J; 2010 Mar; 31(5):522-4. PubMed ID: 20150323
[No Abstract] [Full Text] [Related]
22. Thrombin functions and antithrombotic intervention.
Fenton JW
Thromb Haemost; 1995 Jul; 74(1):493-8. PubMed ID: 8578512
[No Abstract] [Full Text] [Related]
23. [The effect of fibrinolysin with heparin and thrombolytin on blood coagulation indices in myocardial infarct patients with thromboembolic complications].
Panchenko VM; Dmitrieva ZA; Pastorova VE
Ter Arkh; 1971 Aug; 43(8):95-9. PubMed ID: 4261359
[No Abstract] [Full Text] [Related]
24. Use of alpha-adrenoceptor antagonist dihydroergotoxin in experimental anticoagulant and fibrinolytic therapy.
Kalishevskaya TM; Golubeva MG; Bashkov GV
Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(1-2):157-61. PubMed ID: 2459012
[TBL] [Abstract][Full Text] [Related]
25. Antithrombotics for PCI: an indigenous direct thrombin inhibitor (DTI) makes the cut.
Mukherjee D
Indian Heart J; 2008; 60(4):284-6. PubMed ID: 19242003
[No Abstract] [Full Text] [Related]
26. Revival of plasmin as a therapeutic agent?
Collen D
Thromb Haemost; 2001 Sep; 86(3):731-2. PubMed ID: 11583301
[No Abstract] [Full Text] [Related]
27. Development of catheter-directed intrathrombus thrombolysis with plasmin for the treatment of acute lower extremity arterial occlusion.
Comerota AJ
Thromb Res; 2008; 122 Suppl 3():S20-6. PubMed ID: 18701142
[TBL] [Abstract][Full Text] [Related]
28. [Effect of a combination of fibrinolysin, heparin and a fibrinolysin-heparin complex with dihydroergotoxine on thrombolysis].
Kalishevskaia TM; Golubeva MG; Bashkov GV; Vinter VB
Fiziol Zh (1978); 1988; 34(3):88-93. PubMed ID: 2842201
[No Abstract] [Full Text] [Related]
29. Locally delivered plasmin: why should it be superior to plasminogen activators for direct thrombolysis?
Novokhatny VV; Jesmok GJ; Landskroner KA; Marder VJ; Zimmerman TP
Trends Pharmacol Sci; 2004 Feb; 25(2):72-5. PubMed ID: 15102492
[TBL] [Abstract][Full Text] [Related]
30. Antithrombotic benefits and hemorrhagic risks of direct thrombin antagonists.
Harker LA; Hanson SR; Kelly AB
Thromb Haemost; 1995 Jul; 74(1):464-72. PubMed ID: 8578508
[No Abstract] [Full Text] [Related]
31. Belgian biotech's clot-buster approved for aging eyes.
Sheridan C
Nat Biotechnol; 2012 Dec; 30(12):1158. PubMed ID: 23222770
[No Abstract] [Full Text] [Related]
32. [Fibrinolytic therapy].
Beyer J; Schellong S
Hamostaseologie; 2005 Nov; 25(4):345-55. PubMed ID: 16395484
[TBL] [Abstract][Full Text] [Related]
33. New developments in acute anticoagulation therapy: what improvements over traditional heparin are on the horizon?
Carter CJ
Postgrad Med; 1996 Jun; 99(6):129-36. PubMed ID: 8668626
[TBL] [Abstract][Full Text] [Related]
34. [Antithrombotic agents in clinical practice].
Pichard A
Arch Mal Coeur Vaiss; 2006 Feb; 99 Spec no.3():23-5. PubMed ID: 16553240
[TBL] [Abstract][Full Text] [Related]
35. Direct thrombin inhibitors: appraisal of the antithrombotic/hemorrhagic balance.
Verstraete M
Thromb Haemost; 1997 Jul; 78(1):357-63. PubMed ID: 9198179
[No Abstract] [Full Text] [Related]
36. Beyond unfractionated heparin and warfarin: current and future advances.
Hirsh J; O'Donnell M; Eikelboom JW
Circulation; 2007 Jul; 116(5):552-60. PubMed ID: 17664384
[No Abstract] [Full Text] [Related]
37. Treatment of cerebrovascular thrombosis with plasmin and plasminogen activators.
Meyer JS; Herndon RM; Johnson JF; Barnhart M
Res Publ Assoc Res Nerv Ment Dis; 1966; 41():373-98. PubMed ID: 4224934
[No Abstract] [Full Text] [Related]
38. Current use of biologicals in thrombosis and haemostasis.
Ofosu FA; Barrowcliffe TW
Thromb Haemost; 2008 May; 99(5):805-6. PubMed ID: 18449409
[No Abstract] [Full Text] [Related]
39. The fibrinolytic system and its pharmacologic activation for thrombolysis.
Sherry S
Cardiol Clin; 1987 Feb; 5(1):1-11. PubMed ID: 2951008
[TBL] [Abstract][Full Text] [Related]
40. Bivalirudin.
Warkentin TE; Greinacher A; Koster A
Thromb Haemost; 2008 May; 99(5):830-9. PubMed ID: 18449412
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
